| 发明名称 | Methods for treating and/or limiting development of diabetes | ||
| 摘要 | The present invention provides methods for identifying candidate compounds for limiting development of and/or treating diabetes, and methods for limiting development of and/or treating diabetes. | ||
| 申请公布号 | US9353183(B2) | 申请公布日期 | 2016.05.31 |
| 申请号 | US201514717903 | 申请日期 | 2015.05.20 |
| 申请人 | BioCrine AB | 发明人 | Berggren Per Olof;Yang Shao-Nian |
| 分类号 | A61K38/00;A61K31/47;A61K39/395;C07K16/28;G01N33/50;A61K31/472;A61K31/496;A61K31/7076;A61K31/713;C12N15/113;C12N15/115 | 主分类号 | A61K38/00 |
| 代理机构 | McDonnell Boehnen Hulbert & Berghoff LLP | 代理人 | McDonnell Boehnen Hulbert & Berghoff LLP |
| 主权项 | 1. A method for treating or limiting development of diabetes, comprising administering to a subject in need thereof with an amount effective of an inhibitor of protein kinase A (PKA), an inhibitor of Src kinase and an inhibitor of β1 integrin expression and/or activity, wherein the inhibitor of β1 integrin expression and/or activity is an anti-β1 integrin antibody, to treat or limit development of diabetes. | ||
| 地址 | Stockholm SE | ||